BNTX (BioNTech SE) Inventories, Raw Materials & Components: $0 Mil (As of Mar. 2026)


BNTX BioNTech SE BNTX
62 GF Score
Price $94.26
GF Value $89.10
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is BioNTech SE Inventories, Raw Materials & Components?

BioNTech SE BNTX +3.33% 62 Inventories, Raw Materials & Components is $0 Mil as of Mar. 2026. GuruFocus rates BNTX with a GF Score™ of 62/100 and a GF Value™ of $89.10 (Fairly Valued). The stock has 5 warning signs investors should review.

BioNTech SE's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0 Mil.

BioNTech SE's quarterly raw materials increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($115 Mil) but then declined from Dec. 2025 ($115 Mil) to Mar. 2026 ($0 Mil).

BioNTech SE's annual raw materials declined from Dec. 2023 ($379 Mil) to Dec. 2024 ($281 Mil) and declined from Dec. 2024 ($281 Mil) to Dec. 2025 ($115 Mil).

BioNTech SE Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for BioNTech SE's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNTech SE Inventories, Raw Materials & Components Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 280.57 434.00 378.95 280.73 114.87

BioNTech SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 114.87 0.00
BNTX
62GF Score
BioNTech SE BNTX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioNTech SE Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0 Mil mean?
BioNTech SE (BNTX) has a Inventories, Raw Materials & Components of $0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on BioNTech SE and its competitors.
Is BioNTech SE's Inventories, Raw Materials & Components too high?
BioNTech SE's current Inventories, Raw Materials & Components is $0 Mil. Overall, BioNTech SE has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioNTech SE's Inventories, Raw Materials & Components compare to INCY and INSM?
BioNTech SE's Inventories, Raw Materials & Components of $0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on BioNTech SE and its competitors. BioNTech SE's current Inventories, Raw Materials & Components is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNTech SE stock overvalued right now?
Based on GuruFocus' analysis, BioNTech SE (BNTX) is currently considered Fairly Valued. The stock's GF Value™ is $89.10, compared to a current price of $94.26 — trading 5.8% above its estimated fair value. The current Inventories, Raw Materials & Components is $0 Mil. BioNTech SE's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For BioNTech SE (BNTX), the current Inventories, Raw Materials & Components is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioNTech SE (BNTX) Overvalued in 2026?

Based on GuruFocus' analysis, BioNTech SE stock appears to be overvalued. The current stock price of $94.26 is trading 5.8% above its estimated GF Value™ of $89.10. GuruFocus considers BioNTech SE to be Fairly Valued.

Key valuation signals for BNTX:

  • Inventories, Raw Materials & Components: $0 Mil
  • GF Value™: $89.10 vs. price of $94.26 (5.8% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BNTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioNTech SE Business Description

Address An der Goldgrube 12, Mainz, RP, DEU, D-55131
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
62GF Score

Get the complete analysis for BNTX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$94.26
Price
$89.10
GF Value